GW Pharmaceuticals GWP GW to Present at Lazard Healthcare Conference

  GW Pharmaceuticals (GWP) - GW to Present at Lazard Healthcare Conference

RNS Number : 8253Q
GW Pharmaceuticals PLC
12 November 2012




                                      

  GW Pharmaceuticalsto Present at Lazard Healthcare Conference in New York



Porton Down, UK;  12 November 2012:  GW Pharmaceuticals plc  (AIM: GWP)  today 
announces that  itsManaging  Director,Justin  Gover will  be  presenting  at 
theLazard Capital  Markets  9^th  Annual Healthcare  Conference  inNew  York 
onTuesday, 13 November 2012 at11.30am EST (4.30pmGMT). A live webcast  will 
be accessible via the investor relations section of the GW website.



                                    -ends-



Enquiries:



GW Pharmaceuticals plc                      (Today) + 44 20 7831 3113
Dr Geoffrey Guy, Chairman               (Thereafter) + 44 1980 557000
Justin Gover, Managing Director
FTI Consulting                                      + 44 20 7831 3113
Ben Atwell / John Dineen / Simon Conway
  Peel Hunt LLP                                 +44 (0)20 7418 8900
  James Steel / Vijay Barathan                                    





Note to Editors



About GW

GW was founded in  1998 and listed on  the AIM, a market  of the London  Stock 
Exchange, in June 2001. Operating under  license from the UK Home Office,  the 
company  researches  and  develops  cannabinoid  pharmaceutical  products  for 
patients who suffer from a range  of serious ailments, in particular  multiple 
sclerosis and cancer pain. GW has  assembled a large in-house scientific  team 
with expertise in cannabinoid science as well as experience in the development
of  both  plant-based  prescription  pharmaceutical  products  and   medicines 
containing controlled  substances. GW  occupies a  world leading  position  in 
cannabinoids and has developed an extensive international network of the  most 
prominent scientists  in  the field.  For  further information,  please  visit 
www.gwpharm.com





                     This information is provided by RNS
           The company news service from the London Stock Exchange

END


NRAFSLFWUFESEDF -0- Nov/12/2012 07:01 GMT
 
Press spacebar to pause and continue. Press esc to stop.